ROTE WILLIAM E. (Senior Vice President, R&D) sold 68.0% of their position (209.05K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $13.14M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+39K
Price / share
$25.25
Trade value
$984.75K
% of position
Common Stock
Shares
+39.65K
Price / share
$17.96
Trade value
$712.11K
% of position
Common Stock
Shares
−63.91K
Price / share
$61.99
Trade value
$3.96M
% of position
Common Stock
Shares
−29.02K
Price / share
$62.66
Trade value
$1.82M
% of position
Common Stock
Shares
−3K
Price / share
$63.65
Trade value
$190.95K
% of position
Common Stock
Shares
−270.00
Price / share
$65.31
Trade value
$17.63K
% of position
Common Stock
Shares
+350.00
Price / share
$17.96
Trade value
$6.29K
% of position
Common Stock
Shares
+55K
Price / share
$15.46
Trade value
$850.30K
% of position
Common Stock
Shares
+57.50K
Price / share
$26.88
Trade value
$1.55M
% of position
Common Stock
Shares
−65.10K
Price / share
$63.12
Trade value
$4.11M
% of position
Common Stock
Shares
−47.75K
Price / share
$63.61
Trade value
$3.04M
% of position
Net shares
−17.55K
Net value
-$9.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +39K | $25.25 | $984.75K | 33.7% | 115.75K | 154.75K |
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +39.65K | $17.96 | $712.11K | 25.6% | 154.75K | 194.40K |
| Common Stock Direct | 9/15/2026 | S · Sale | −63.91K | $61.99 | $3.96M | 32.9% | 194.40K | 130.49K |
| Common Stock Direct | 9/15/2026 | S · Sale | −29.02K | $62.66 | $1.82M | 22.2% | 130.49K | 101.47K |
| Common Stock Direct | 9/15/2026 | S · Sale | −3K | $63.65 | $190.95K | 3.0% | 101.47K | 98.47K |
| Common Stock Direct | 9/15/2026 | S · Sale | −270.00 | $65.31 | $17.63K | 0.3% | 98.47K | 98.20K |
| Common Stock Direct | 9/16/2026 | M · Option Exercise | +350.00 | $17.96 | $6.29K | 0.4% | 98.20K | 98.55K |
| Common Stock Direct | 9/16/2026 | M · Option Exercise | +55K | $15.46 | $850.30K | 55.8% | 98.55K | 153.55K |
| Common Stock Direct | 9/16/2026 | M · Option Exercise | +57.50K | $26.88 | $1.55M | 37.4% | 153.55K | 211.05K |
| Common Stock Direct | 9/16/2026 | S · Sale | −65.10K | $63.12 | $4.11M | 30.8% | 211.05K | 145.94K |
| Common Stock Direct | 9/16/2026 | S · Sale | −47.75K | $63.61 | $3.04M | 32.7% | 145.94K | 98.20K |
| Total | −17.55K | -$9.04M | ||||||
Employee stock option (right to buy)
Common Stock
39K shares
Shares
−39K
Strike price
25.25
Held after
0.00
Exercisable
—
Employee stock option (right to buy)
Common Stock
39.65K shares
Shares
−39.65K
Strike price
17.96
Held after
350.00
Exercisable
—
Employee stock option (right to buy)
Common Stock
350.00 shares
Shares
−350.00
Strike price
17.96
Held after
0.00
Exercisable
—
Employee stock option (right to buy)
Common Stock
55K shares
Shares
−55K
Strike price
15.46
Held after
0.00
Exercisable
—
Employee stock option (right to buy)
Common Stock
57.50K shares
Shares
−57.50K
Strike price
26.88
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock39K shares | 9/15/2026 | M · Option Exercise | −39K | 25.25 | — | 0.00 |
| Employee stock option (right to buy) Direct | Common Stock39.65K shares | 9/15/2026 | M · Option Exercise | −39.65K | 17.96 | — | 350.00 |
| Employee stock option (right to buy) Direct | Common Stock350.00 shares | 9/16/2026 | M · Option Exercise | −350.00 | 17.96 | — | 0.00 |
| Employee stock option (right to buy) Direct | Common Stock55K shares | 9/16/2026 | M · Option Exercise | −55K | 15.46 | — | 0.00 |
| Employee stock option (right to buy) Direct | Common Stock57.50K shares | 9/16/2026 | M · Option Exercise | −57.50K | 26.88 | — | 0.00 |